CompletedPHASE2, PHASE3NCT00915343

Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency

Studying Addison disease

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Shire
Principal Investigator: Maria Forss, MSc BA
DuoCort AB
Intervention: hydrocortisone (modified release), oral tablet 20 and 5 mg(drug)
Enrollment: 64 enrolled
Eligibility: 18 years · All sexes
Timeline: 2007 – 2009

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00915343 on ClinicalTrials.gov

Other trials for Addison disease

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06955286
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
Qifu Li

See all trials for Addison disease →

← Back to all trials